L

Lawrence J Green, MD LLC | Rockville, MD

Research site

(Unclaimed)

Location

9601 Blackwell Road Suite 260, Rockville, Maryland, United States of America

Site insights

Top conditions

Top treatments

VP-315

TAK-279

Ritlecitinib

Glycopyrronium

Sofpironium Bromide

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials

Locations recently updated

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents with Nonsegmental Vitiligo (Active and Stable) Tranquillo

Enrolling

Stable Nonsegmental Vitiligo

Active Nonsegmental Vitiligo

Drug: Ritlecitinib

Drug: Placebo

Locations recently updated

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

The main aim of this study is to show how well TAK-279 reduces the skin plaques compared to placebo, in participants with moderate-to-severe plaque p...

Enrolling

Plaque Psoriasis

Drug: TAK-279

Drug: Placebo

Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma

This is a 2-part, open-label, multicenter, dose-escalation, proof-of-concept study with a safety run-in designed to assess the safety, tolerability,...

Enrolling

Cancer of the Skin, Basal Cell

Skin Cancer

Drug: LTX-315 Part 1

Drug: VP-315 Part 2